{
    "2020-12-26": [
        [
            {
                "time": "2020-12-26",
                "original_text": "【浙商医药|周报】CXO龙头新高下的思考：空间、趋势和供需 ──医药行业周报20201226",
                "features": {
                    "keywords": [
                        "CXO",
                        "龙头",
                        "新高",
                        "医药",
                        "空间",
                        "趋势",
                        "供需"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-00-00",
                "original_text": "前程无忧2021人力资源管理杰出奖榜单揭晓",
                "features": {
                    "keywords": [
                        "前程无忧",
                        "人力资源",
                        "管理",
                        "杰出奖"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-00-00",
                "original_text": "电鳗快报|控股股东质押八成持股 羚锐制药股价“逆势”下跌背后",
                "features": {
                    "keywords": [
                        "控股股东",
                        "质押",
                        "羚锐制药",
                        "逆势",
                        "下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-00-00",
                "original_text": "医保谈判结果未出，恒瑞医药股价新高，“医药股一哥”稳了？",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "恒瑞医药",
                        "股价新高",
                        "医药股一哥"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}